The Norwegian Cancer Symposium 2022 on the subject "Sustainable cancer care using molecular tests - from a prostate cancer perspective" will be held Sep 14-15 2022. The 2-day symposium brings together top-ranking researchers, clinicians, industry and policymakers, aiming to strengthen collaboration and overcome hurdles for implementing molecular tests in precision medicine.
We have reached more than 120 participants and 27 submitted abstracts, and we look very much forward to see you all there.
For you who have not signed up, you are welcome to attend individual talks.
This will be for free, but will not include lunch.
For you who have not signed up:
Do to a limited number of seats, it will be on a first come - first served basis, and registration on beforehand is required.
Please send an email with the talks you will attend to NCS2022@norprost.com
Time and place: Sep. 14, 2022 - Sep. 15, 2022, Clarion Oslo, Bjørvika, Oslo
We would like to extend an invitation to The Norwegian Cancer Symposium 2022 on Sustainable cancer care using molecular tests.
The 2-day symposium brings together top-ranking researchers, clinicians, industry and policymakers. We aim to strengthen collaboration and overcome hurdles for implementing molecular tests in precision medicine.
Topics include the following:
- Will molecular tests enable sustainable precision medicine?
- Providing evidence for implementing molecular tests in clinical guidelines
- Precision medicine: impact of the tumour environment
- Pitfalls and opportunities in biomarker discovery
- Panel discussion (in Norwegian):
How and when can molecular tests provide sustainable precision medicine in the clinic?
Abstract deadline: June 1st 2022
Registration deadline: June 15th 2022
Limited spaces available, early registration recommended!
For registration and overview of speakers and program, please visit the symposium web site:
On behalf of the organizing committee,